Tandem Diabetes Care
TNDM
62 hedge funds and large institutions have $210M invested in Tandem Diabetes Care in 2014 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 29 reducing their positions, and 15 closing their positions.
5% less funds holding
Funds holding: 65 → 62 (-3)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
21% less capital invested
Capital invested by funds: $266M → $210M (-$56.4M)
45% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 29
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $16K
Top Buyers
Top Sellers
| 1 |
PC
Pier Capital
Stamford,
Connecticut
|
-$2.68M |
| 2 |
MACM
March Altus Capital Management
Greenwich,
Connecticut
|
-$2.62M |
| 3 |
VAM
Visium Asset Management
New York
|
-$2.55M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$2.54M |
| 5 |
PA
Perceptive Advisors
New York
|
-$2.34M |
TNDM Hedge Fund Activity: Q2 2014 in Review
62 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q2 2014, worth a combined $210M — down 21% from $266M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of TNDM and 12 opened new positions — a net loss of 3 holders — while 29 trimmed existing stakes and 16 added.
The largest buyer was Franklin Resources, adding an estimated $13.3M. The largest seller was Pier Capital, cutting an estimated $2.68M.
- 62 institutional investors held Tandem Diabetes Care (TNDM) as of Q2 2014, down from 65 in Q1 2014.
- Funds reported $210M of Tandem Diabetes Care stock for Q2 2014, down 21% quarter-over-quarter.
- 12 funds opened new Tandem Diabetes Care positions in Q2 2014 and 15 closed out, a net change of -3 holders.
- The largest Tandem Diabetes Care buyer in Q2 2014 was Franklin Resources, an estimated $13.3M added.
- The largest Tandem Diabetes Care seller in Q2 2014 was Pier Capital, an estimated $2.68M sold.
Based on aggregated 13F filings for Q2 2014.